• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对人乳头瘤病毒6型L1病毒样颗粒的单克隆抗体,除了能识别6型特异性表位外,还能识别11型人乳头瘤病毒上的构象性和线性中和表位。

Monoclonal antibodies to HPV-6 L1 virus-like particles identify conformational and linear neutralizing epitopes on HPV-11 in addition to type-specific epitopes on HPV-6.

作者信息

Christensen N D, Reed C A, Cladel N M, Hall K, Leiserowitz G S

机构信息

Department of Pathology, Milton S. Hershey Medical Center, Hershey, Pennsylvania 17033, USA.

出版信息

Virology. 1996 Oct 15;224(2):477-86. doi: 10.1006/viro.1996.0554.

DOI:10.1006/viro.1996.0554
PMID:8874508
Abstract

A set of 13 monoclonal antibodies (MAbs) was generated against HPV-6 L1 virus-like particles (VLPs), screened for reactivity to HPV-6 and HPV-11 L1 VLPs by ELISA, and tested for neutralization of HPV-11 infection. Both cross-reactive and type-specific epitopes were detected such that 4 of 13 MAbs reacted to surface conformational sites on HPV-6 L1 VLPs and the remaining 9 MAbs were cross-reactive to both HPV-6 and HPV-11 L1 VLPs. four of the 9 cross-reactive MAbs were able to neutralize HPV-11 infectivity, and 3 of 4 of these neutralizing MAbs (N-MAbs) identified shared surface conformational sites. One N-MAb therefore recognized a surface linear epitope as judged by positive binding to L1 in a Western blot assay. The neutralization status of these cross-reactive MAbs with regard to HPV-6 could not be assayed. These results demonstrated that the closely related HPV types 6 and 11 contain both type-specific and shared neutralizing epitopes.

摘要

针对人乳头瘤病毒6型(HPV-6)L1病毒样颗粒(VLP)产生了一组13种单克隆抗体(MAb),通过酶联免疫吸附测定(ELISA)筛选其与人乳头瘤病毒6型和11型(HPV-11)L1 VLP的反应性,并测试其对HPV-11感染的中和作用。检测到了交叉反应性表位和型特异性表位,13种MAb中有4种与人乳头瘤病毒6型L1 VLP的表面构象位点发生反应,其余9种MAb与人乳头瘤病毒6型和11型L1 VLP均发生交叉反应。9种交叉反应性MAb中有4种能够中和HPV-11的感染性,其中4种中和性MAb(N-MAb)中有3种识别出共同的表面构象位点。因此,通过蛋白质印迹分析中与L1的阳性结合判断,一种N-MAb识别出一个表面线性表位。无法测定这些交叉反应性MAb对HPV-6的中和状态。这些结果表明,密切相关的HPV-6型和11型既包含型特异性中和表位,也包含共同的中和表位。

相似文献

1
Monoclonal antibodies to HPV-6 L1 virus-like particles identify conformational and linear neutralizing epitopes on HPV-11 in addition to type-specific epitopes on HPV-6.针对人乳头瘤病毒6型L1病毒样颗粒的单克隆抗体,除了能识别6型特异性表位外,还能识别11型人乳头瘤病毒上的构象性和线性中和表位。
Virology. 1996 Oct 15;224(2):477-86. doi: 10.1006/viro.1996.0554.
2
Hybrid papillomavirus L1 molecules assemble into virus-like particles that reconstitute conformational epitopes and induce neutralizing antibodies to distinct HPV types.杂交乳头瘤病毒L1分子组装成病毒样颗粒,这些颗粒可重构构象表位并诱导针对不同HPV类型的中和抗体。
Virology. 2001 Dec 20;291(2):324-34. doi: 10.1006/viro.2001.1220.
3
Surface conformational and linear epitopes on HPV-16 and HPV-18 L1 virus-like particles as defined by monoclonal antibodies.由单克隆抗体定义的人乳头瘤病毒16型和18型L1病毒样颗粒上的表面构象表位和线性表位
Virology. 1996 Sep 1;223(1):174-84. doi: 10.1006/viro.1996.0466.
4
Type-specific and cross-reactive antibodies induced by human papillomavirus 31 L1/L2 virus-like particles.人乳头瘤病毒31型L1/L2病毒样颗粒诱导的型特异性和交叉反应性抗体。
J Med Microbiol. 2007 Jul;56(Pt 7):907-913. doi: 10.1099/jmm.0.47073-0.
5
Identification of two cross-neutralizing linear epitopes within the L1 major capsid protein of human papillomaviruses.人乳头瘤病毒L1主要衣壳蛋白内两个交叉中和线性表位的鉴定
J Virol. 2002 Jul;76(13):6480-6. doi: 10.1128/jvi.76.13.6480-6486.2002.
6
Mutations on the FG surface loop of human papillomavirus type 16 major capsid protein affect recognition by both type-specific neutralizing antibodies and cross-reactive antibodies.人乳头瘤病毒16型主要衣壳蛋白FG表面环上的突变会影响型特异性中和抗体和交叉反应抗体的识别。
J Med Virol. 2005 Dec;77(4):558-65. doi: 10.1002/jmv.20492.
7
Identification of type-specific and cross-reactive neutralizing conformational epitopes on the major capsid protein of human papillomavirus type 31.人乳头瘤病毒31型主要衣壳蛋白上型特异性和交叉反应性中和构象表位的鉴定
Arch Virol. 2006 Aug;151(8):1511-23. doi: 10.1007/s00705-006-0734-y. Epub 2006 Mar 3.
8
Human papillomavirus types 6 and 11 have antigenically distinct strongly immunogenic conformationally dependent neutralizing epitopes.6型和11型人乳头瘤病毒具有抗原性不同的、强烈免疫原性的、构象依赖性中和表位。
Virology. 1994 Nov 15;205(1):329-35. doi: 10.1006/viro.1994.1649.
9
Chimeric human papillomavirus type 16 (HPV-16) L1 particles presenting the common neutralizing epitope for the L2 minor capsid protein of HPV-6 and HPV-16.呈现人乳头瘤病毒6型(HPV-6)和人乳头瘤病毒16型(HPV-16)次要衣壳蛋白L2共同中和表位的嵌合人乳头瘤病毒16型(HPV-16)L1颗粒。
J Virol. 2003 Aug;77(15):8386-93. doi: 10.1128/jvi.77.15.8386-8393.2003.
10
Binding and neutralization efficiencies of monoclonal antibodies, Fab fragments, and scFv specific for L1 epitopes on the capsid of infectious HPV particles.针对感染性人乳头瘤病毒(HPV)颗粒衣壳上L1表位的单克隆抗体、Fab片段和单链抗体(scFv)的结合及中和效率。
Virology. 2007 May 10;361(2):435-46. doi: 10.1016/j.virol.2006.12.002. Epub 2007 Jan 12.

引用本文的文献

1
Human Papillomavirus Type 16 Stimulates WAVE1- and WAVE2-Dependent Actin Protrusions for Endocytic Entry.16型人乳头瘤病毒刺激依赖WAVE1和WAVE2的肌动蛋白突起以实现内吞进入。
Viruses. 2025 Apr 8;17(4):542. doi: 10.3390/v17040542.
2
A Combined LC-MS and Immunoassay Approach to Characterize Preservative-Induced Destabilization of Human Papillomavirus Virus-like Particles Adsorbed to an Aluminum-Salt Adjuvant.一种结合液相色谱-质谱联用和免疫分析的方法来表征吸附于铝盐佐剂的人乳头瘤病毒样颗粒中防腐剂诱导的稳定性破坏
Vaccines (Basel). 2024 May 26;12(6):580. doi: 10.3390/vaccines12060580.
3
Development of a proficiency testing program for HPV serology assays used to evaluate antibody responses in vaccine trials.
HPV 血清学检测能力验证计划的制定,用于评估疫苗试验中的抗体反应。
J Immunol Methods. 2023 Dec;523:113585. doi: 10.1016/j.jim.2023.113585. Epub 2023 Nov 9.
4
The second HPV serology meeting: Progress and challenges in standardization of human papillomavirus serology assays.第二届 HPV 血清学会议:HPV 血清学检测标准化的进展与挑战。
Vaccine. 2023 Feb 3;41(6):1177-1181. doi: 10.1016/j.vaccine.2023.01.008. Epub 2023 Jan 13.
5
Immunogenicity correlation in cynomolgus monkeys between Luminex-based total IgG immunoassay and pseudovirion-based neutralization assay for a 14-valent recombinant human papillomavirus vaccine.基于 Luminex 的总 IgG 免疫分析与基于假病毒中和试验在 14 价重组人乳头瘤病毒疫苗的食蟹猴中的免疫原性相关性。
J Med Virol. 2022 Aug;94(8):3946-3955. doi: 10.1002/jmv.27763. Epub 2022 Apr 21.
6
L1 Recombinant Proteins of HPV Tested for Antibody Forming Using Sera of HPV Quadrivalent Vaccine.使用四价人乳头瘤病毒(HPV)疫苗血清检测HPV的L1重组蛋白诱导抗体形成的能力
Immune Netw. 2018 Jun 4;18(3):e19. doi: 10.4110/in.2018.18.e19. eCollection 2018 Jun.
7
Expanded strain coverage for a highly successful public health tool: Prophylactic 9-valent human papillomavirus vaccine.扩大高度成功的公共卫生工具的菌株覆盖范围:预防性九价人乳头瘤病毒疫苗。
Hum Vaccin Immunother. 2017 Oct 3;13(10):2280-2291. doi: 10.1080/21645515.2017.1346755.
8
Description of a novel multiplex avidity assay for evaluating HPV antibodies.一种用于评估人乳头瘤病毒抗体的新型多重亲和力检测方法的描述。
J Immunol Methods. 2017 Aug;447:31-36. doi: 10.1016/j.jim.2017.04.004. Epub 2017 Apr 19.
9
Epitomics: IgG-epitome decoding of E6, E7 and L1 proteins from oncogenic human papillomavirus type 58.表位组学:从致癌性人乳头瘤病毒 58 型中 E6、E7 和 L1 蛋白的 IgG-表位解码
Sci Rep. 2016 Oct 6;6:34686. doi: 10.1038/srep34686.
10
Lessons learned from successful human vaccines: Delineating key epitopes by dissecting the capsid proteins.从成功的人类疫苗中汲取的经验教训:通过剖析衣壳蛋白来确定关键表位。
Hum Vaccin Immunother. 2015;11(5):1277-92. doi: 10.1080/21645515.2015.1016675.